πŸ•΅οΈ Cytokinetics Inc ($CYTK)

SEC insider & ownership activity, last 12 months Β· CIK 1061983 Β· every row links its SEC filing

Over the last 12 months insiders sold $42.4M with no open-market buying against it. Callos Andrew sold $14.2M through a 10b5-1 trading plan in 23 lots (Dec–Jul). 1 planned sale is pending, the largest $3.1M (Sung Lee). No red-flag 8-Ks in the window.

🚨 2 signals active β€” planned-vs-executed verdicts, pre-event flags, and cluster context live in the API and the alerts bot.
Aug 2025: net -$341K Sep 2025: net -$1.5M Oct 2025: net -$1.8M Nov 2025: net -$943K Dec 2025: net -$7.8M Jan 2026: net -$1.0M Mar 2026: net -$7.1M Mar 2026: net -$7.1M Apr 2026: net -$3.4M May 2026: net -$7.3M Jun 2026: net -$6.2M Jul 2026: net -$3.8M
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

0 buyers, $0 (0 lots) Β· 9 sellers, $42.4M (86 lots)

InsiderBuysBoughtSellsSoldLast
Callos Andrew0– 23$14.2MJul 1, 2026
Robert I. Blum0– 20$9.5MJul 27, 2026
Lee Sung0– 5$5.7MJul 1, 2026
Malik Fady Ibraham0– 22$4.2MJul 21, 2026
Kaye Edward M. Md0– 6$3.5MJun 1, 2026
John T. Henderson0– 2$2.1MMay 5, 2026
Wierenga Wendell0– 3$1.9MMay 5, 2026
Parshall B Lynne0– 3$1.0MJun 1, 2026
Harrington Robert Arthur0– 2$248KDec 1, 2025

5%+ holders

HolderStakeClassScheduleEvent
T. ROWE Price Investment Management, Inc. 14.5% 13GFeb 17, 2026 filing β†—
Vanguard Capital Management 5.2% 13GApr 29, 2026 filing β†—
FMR LLC exited 13GJul 8, 2026 filing β†—
Abigail P. Johnson exited 13GJul 8, 2026 filing β†—

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Fady Malik$2.1MJul 7, 2026 filing β†—
Robert Blum$4.5MJul 1, 2026 filing β†—
Sung Lee$781KJun 29, 2026 filing β†—
Sung Lee$541KJun 26, 2026 filing β†—
Sung Lee$3.1MJun 24, 2026 filing β†—
Edward Kaye$225KJun 1, 2026 filing β†—
Wendell Wierenga$266KMay 5, 2026 filing β†—
John Henderson$1.3MMay 5, 2026 filing β†—
Sung Lee$1.6MMay 5, 2026 filing β†—
Andrew Callos$5.3MApr 15, 2026 filing β†—
Fady Malik$1.4MApr 7, 2026 filing β†—
Robert Blum$3.0MApr 1, 2026 filing β†—
Andrew Callos$229KMar 31, 2026 filing β†—
Andrew Callos$120KMar 18, 2026 filing β†—
Andrew Callos$103KMar 16, 2026 filing β†—
B Lynne Parshall$622KMar 2, 2026 filing β†—
Andrew Callos$3.8MJan 2, 2026 filing β†—
Andrew Callos$114KDec 29, 2025 filing β†—
Wendell Wierenga$1.3MDec 22, 2025 filing β†—
Andrew Callos$3.6MDec 5, 2025 filing β†—
John T Henderson$578KDec 2, 2025 filing β†—
Edward Kaye$1.9MDec 1, 2025 filing β†—
B Lynne Parshall$331KNov 19, 2025 filing β†—
Edward Kaye$322KNov 11, 2025 filing β†—
Wendell Wierenga$253KOct 27, 2025 filing β†—
Fady Malik$653KOct 21, 2025 filing β†—
Edward Kaye$385KOct 6, 2025 filing β†—
Robert Blum$824KOct 1, 2025 filing β†—
Edward Kaye$361KSep 30, 2025 filing β†—
Robert Harrington$152KSep 2, 2025 filing β†—
Edward Kaye$239KSep 2, 2025 filing β†—

Material events (8-K)

ItemEvent date
Shareholder vote (5.07)May 27, 2026 filing β†—
Other events (8.01)May 6, 2026 filing β†—
Financial Statements and Exhibits (9.01)May 6, 2026 filing β†—
Other events (8.01)May 5, 2026 filing β†—
Financial Statements and Exhibits (9.01)May 5, 2026 filing β†—
Earnings (2.02)May 5, 2026 filing β†—
Financial Statements and Exhibits (9.01)May 5, 2026 filing β†—
Earnings (2.02)Feb 24, 2026 filing β†—
Financial Statements and Exhibits (9.01)Feb 24, 2026 filing β†—
Other events (8.01)Feb 17, 2026 filing β†—
Other events (8.01)Dec 19, 2025 filing β†—
Other events (8.01)Dec 12, 2025 filing β†—
Officer/director changes (5.02)Nov 13, 2025 filing β†—
Earnings (2.02)Nov 5, 2025 filing β†—
Financial Statements and Exhibits (9.01)Nov 5, 2025 filing β†—
Material agreement (1.01)Sep 16, 2025 filing β†—
New financial obligation (2.03)Sep 16, 2025 filing β†—
Unregistered equity sale (3.02)Sep 16, 2025 filing β†—
Other events (8.01)Sep 16, 2025 filing β†—
Financial Statements and Exhibits (9.01)Sep 16, 2025 filing β†—
Other events (8.01)Sep 15, 2025 filing β†—
Other events (8.01)Aug 31, 2025 filing β†—
Financial Statements and Exhibits (9.01)Aug 31, 2025 filing β†—
Other events (8.01)Aug 31, 2025 filing β†—
Financial Statements and Exhibits (9.01)Aug 31, 2025 filing β†—
Other events (8.01)Aug 30, 2025 filing β†—
Financial Statements and Exhibits (9.01)Aug 30, 2025 filing β†—
Officer/director changes (5.02)Aug 19, 2025 filing β†—
Earnings (2.02)Aug 7, 2025 filing β†—
Financial Statements and Exhibits (9.01)Aug 7, 2025 filing β†—